focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnexo Group Plc Regulatory News (ANX)

Share Price Information for Anexo Group Plc (ANX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.00
Ask: 70.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.941%)
Open: 70.00
High: 70.00
Low: 68.60
Prev. Close: 69.00
ANX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Anexo Group plc

7 Jul 2021 14:25

RNS Number : 5116E
Anexo Group PLC
07 July 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Anexo Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Anexo Group plc

(d) Is the discloser the offeror or the offeree?

Offeree

(e) Date position held:

The latest practicable date prior to the disclosure

6 July 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

n/a

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

 

TOTAL:

Nil

0

Nil

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

n/a

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

3(a) - Interests of the directors of Anexo Group plc (and their close relatives and related trusts) in ordinary shares of Anexo Group plc

 

Director (unless otherwise specified)

Number of ordinary shares

Percentage of total issued share capital (%)

Mark Bringloe

15,000

0.01

Elizabeth Sands

4,290

0.00

Wendy Bringloe (close relative)

47,335

0.04

* the interests of Alan Sellers and Samantha Moss, directors of Anexo Group plc, have been separately disclosed pursuant to Rule 8

3(b) - Interests of directors of Anexo Group plc (and their close relatives and related trusts) in Anexo Group plc share options/awards in respect of ordinary shares:

 

Anexo Group plc (Anexo") Management Incentive Plan (MIP)

 

Director

 

Vested* (Anexo shares unissued)

Unvested* (vesting date 1 January 2022)

 

Exercise price

Mark Bringloe

250,000

250,000

Nil

Dawn O'Brien

250,000

250,000

Nil

* MIP awards may be settled in cash or in Anexo shares. Further details of the MIP are set out in the Anexo 2021 Annual Report, available on the Anexo website www.anexo-group.com

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

 

 

Date of disclosure:

7 July 2021

Contact name:

Nick Dashwood Brown

Telephone number:

07971 36 20 20

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEXDLFBFDLLBBL
Date   Source Headline
7th Apr 20217:00 amRNSAppointment of Joint Corporate Broker
18th Mar 20211:18 pmRNSHolding(s) in Company
3rd Mar 20217:00 amRNSAcquisition of Shares by Major Shareholder
5th Feb 20214:41 pmRNSSecond Price Monitoring Extn
5th Feb 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSFY 2020 Trading Update
13th Nov 20204:27 pmRNSNOTIFICATION OF MAJOR HOLDINGS
12th Nov 20207:00 amRNSAcquisition of Shares and Trading Update
9th Sep 20205:26 pmRNSNOTIFICATION OF MAJOR HOLDINGS
13th Aug 20207:00 amRNSInterim Results
22nd Jul 202011:30 amRNSResult of AGM
22nd Jul 20207:00 amRNSAGM Trading Update
29th Jun 20205:17 pmRNSAnnual Report and Notice of AGM
29th Jun 20202:36 pmRNSProgressive publishes new research
29th Jun 20207:00 amRNSFinal Results
25th Jun 202012:00 pmRNSNotice of Final Results
29th May 20201:04 pmRNSResult of Placing
29th May 20207:00 amRNSProposed Placing of £11 million
8th Apr 20207:00 amRNSHigh Court Judgment re. Volkswagen
3rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:36 pmRNSPrice Monitoring Extension
3rd Apr 20207:00 amRNSFY-19 Results, COVID-19 Update and Trading Update
6th Mar 20204:02 pmRNSNotification of Major Holdings
5th Mar 20206:06 pmRNSREPLACEMENT: Director/PDMR Shareholding
5th Mar 20209:00 amRNSREPLACEMENT: Director/PDMR Shareholding
5th Mar 20207:00 amRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNSAppointment of Joint Corporate Broker
28th Jan 20207:00 amRNSTrading Update and Notice of Results
23rd Jan 202011:31 amRNSNotification of Major Holdings
14th Nov 20195:07 pmRNSDirector/PDMR Shareholding
2nd Oct 20198:16 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
1st Oct 20198:16 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
30th Sep 20198:16 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
30th Sep 20197:00 amRNSNotice of Capital Markets Day
27th Sep 20198:16 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
26th Sep 20198:17 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
25th Sep 20198:15 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
24th Sep 20198:17 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
23rd Sep 20198:16 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
20th Sep 20198:15 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
19th Sep 20198:16 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
18th Sep 20198:17 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
17th Sep 20198:15 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
16th Sep 20198:16 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
13th Sep 20198:16 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
12th Sep 20198:17 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
11th Sep 20197:16 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
10th Sep 20198:16 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)
10th Sep 20197:00 amRNSInterim Results
9th Sep 20198:15 amEQSAMUNDI ETF NASDAQ-100 - A: Net Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.